Abstract: Provided are a server and a system which enable a worker of a work machine to intuitively recognize work contents and the like to be performed using the work machine in each of a plurality of work locations. In response to a first designated operation through a remote input interface 210 of a remote operation device 20, a remote output interface 220 of the remote operation device 20 outputs a work environment image showing positions of designated work locations Q1 and Q2, and information about at least one of a designated work period and a designated work content. The designated work location, the designated work period and the designated work content are included in designated work information that is work information fitting a designated position depending on the first designated operation among a plurality of pieces of work information registered in a database 102.

Abstract: To achieve a size reduction while making it possible to mold a case housing an axle and a gear mechanism by casting in an electric-vehicle power transmission unit that drives right and left wheels with a single electric motor. [Solution] A power transmission unit 41 includes a motor case 50 that is provided on the same side as a second axle 19 with respect to a center between a first axle 18 and the second axle 19, separated to right and left, in a right-left direction and that houses the electric motor 70, a first axle case 43 housing a reduction gear mechanism 78, a differential gear mechanism 118, and the first axle 18, and a second axle case 130 that is fixed to the first axle case 43 in a separable manner and houses the second axle 19.

Abstract: [Problem] A power transmission unit that improves quietness of a gear mechanism and prevents a size of the unit from increasing when a brake rotor is installed around an input shaft of the gear mechanism. [Solution] The power transmission unit includes an electric driving motor with a motor shaft, a gear mechanism, and an output shaft, which are accommodated in a transmission housing, wherein the power of the motor shaft is transmitted to the output shaft via the gear mechanism. The gear mechanism has a gear shaft rotatably supported on the transmission housing and a first helical gear provided on the gear shaft. The power transmission unit further includes a connecting member provided with a tubular portion fitted to the motor shaft and the gear shaft so as to allow the motor shaft and the gear shaft to synchronously rotate. The connecting member is integrally provided with a brake rotor on the outer periphery thereof.

Abstract: Provided is a method of producing a composite having high strength and high thermal conductivity. The method includes: an alloy preparation step including preparing an alloy which is a solid solution containing ?-Fe as a solvent and at least one type of ?-phase stabilizing element as a solute; a first mixing step including mixing at least one type of ?-phase stabilizing element in powder form and SiC to prepare a first mixture; a second mixing step including mixing the alloy and the first mixture to prepare a second mixture; and a sintering step including sintering the second mixture.

Abstract: An image of the nearby surroundings of a user's vehicle is displayed, which includes images of the user's vehicle and threshold lines that define a range of distance from the user's vehicle. The image of the nearby surroundings of the user's vehicle is changed in accordance with a positional relationship between another vehicle and the range of distance.

Abstract: An image of the nearby surroundings of a user's vehicle is displayed, which includes images of the user's vehicle and threshold lines that define a range of distance from the user's vehicle. The image of the nearby surroundings of the user's vehicle is changed in accordance with a positional relationship between another vehicle and the range of distance.

Abstract: A management computer performs a process comprising: a first step and a second step. The first step collects failure-predictive information including information on a plurality of kinds of phenomena related to occurrence of a failure from each of a plurality of computers including an active first computer in a redundant system that are managed by said management computer. The second step calculates, for each individual second computer of one or more second computers of a plurality of second computers associated with said first computer in said redundant system, an evaluation value that indicates the probability of occurrence of a future failure in the individual second computer using said failure-predictive information collected from the individual second computer and said failure-predictive information collected from one or more predetermined computers other than the individual second computer of said plurality of computers.

Abstract: A management computer performs a process comprising: a first step and a second step. The first step collects failure-predictive information including information on a plurality of kinds of phenomena related to occurrence of a failure from each of a plurality of computers including an active first computer in a redundant system that are managed by said management computer. The second step calculates, for each individual second computer of one or more second computers of a plurality of second computers associated with said first computer in said redundant system, an evaluation value that indicates the probability of occurrence of a future failure in the individual second computer using said failure-predictive information collected from the individual second computer and said failure-predictive information collected from one or more predetermined computers other than the individual second computer of said plurality of computers.

Abstract: The invention relates to compound of the formula (I) or its salt, wherein —R1, —R2, —R3, —R4, —R5, -M-, —X— and —Y? are as defined in the description, their use of as, medicament, the process for their preparation and use for the treatment of JAK3 mediated diseases.

Abstract: The invention relates to compound of the formula (I) or its salt, wherein —R1, —R2, —R3, —R4, —R5, -M-, —X— and —Y? are as defined in the description, their use of as, medicament, the process for their preparation and use for the treatment of JAK3 mediated diseases.

Abstract: Imidazole compounds represented by general formula (I): wherein each symbol is as defined in the specification, and salts thereof, and a pharmaceutical composition containing same are provided. These compounds are useful in treating the diseases curable based on a hypoglycemic action, and the diseases curable based on a cGMP-PDE inhibitory action, a smooth muscle relaxing action, a bronchodilating action, a vasodilating action, a smooth muscle cell inhibitory action and an allergy inhibitory action.

Abstract: The present invention relates to a milk-coagulating enzyme of bacterial origin and a process for producing cheese by using this enzyme, namely, an enzyme that is produced by a bacterium belonging to the genus Paenibacillus and exhibits milk-coagulating activity, characterized by having the following enzymological properties: 1) function: having an activity of coagulating milk to form a curd; 2) substrate specificity: acting on ?-casein as a substrate and specifically cleaving Thr94-Met95 in the presence of calcium; 3) optimum pH: 6.0-7.0, and 4) molecular weight: 35,000-37,000 Da when measured by SDS-PAGE; a process for producing the enzyme; a process for producing cheese; and a cheese-like food product.

Abstract: A sulfonamide compound of the formula (I): R1—SO2NHCO—A—X—R2??(I) wherein R1 is alky, alkenyl, alkynyl and the like; A is an optionally substitutedheteropolycyclic group except benzimidazolyl, indolyl, 4,7-dihydrobenzimidazolyland 2,3-dihydrobenzoxazinyl; X is alkylene, oxa, oxa(lower)alkylene and the like; and R2 is optionally substituted aryl, substituted biphenylyl and the like, a salt thereof and a pharmaceutical composition comprising the same. The sulfonamide compound is effective for the diseases treatable based on their blood sugar level-depressing activity, cGMP-PDE (especially PDE-V)-inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity, smooth muscle cell suppressing activity, and antiallergic activity.

Abstract: The present invention relates to a sulfonamide compound of the formula (I): wherein each symbol is as defined in the specification, a salt thereof, and a pharmaceutical composition containing same. This compound can be an effective agent for the prophylaxis and treatment of the diseases curable based on a hypoglycemic action, and the diseases curable based on a cGMP-PDE inhibitory action, a smooth muscle relaxing action, a bronchodilating action, a vasodilating action, a smooth muscle cell inhibitory action and an allergy suppressing action.

Abstract: The present invention provides novel benzimidazole derivatives of the following formula (I) and salts thereof: wherein R1 represents a lower alkyl group or a lower alkyloxy-lower alkyl group; R2 represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 8 carbon atoms, an aryl group, and such; R3 represents a lower alkyl group, a lower alkenyl group, an aryl group, a lower alkylaryl group, an aryl-lower alkenyl group, a halothienyl group, a lower alkylamino group, or an aryl-lower alkylamino group; A represents a benzene ring, a naphthalene ring, or a pyridine ring; and X represents a halogen atom. The derivatives and their salts have blood sugar level-depressing activity or PDE5-inhibiting activity, and are useful as pharmaceutical preparations.

Abstract: A sulfonamide compound of the formula (I):

Abstract: A sulfonamide compound of the formula (I): R1—SO2NHCO—A—X—R2  (I) wherein R1 is alky, alkenyl, alkynyl and the like; A is an optionally substitutedheteropolycyclic group except benzimidazolyl, indolyl, 4,7-dihydrobenzimidazolyland 2,3-dihydrobenzoxazinyl; X is alkylene, oxa, oxa(lower)alkylene and the like; and R2 is optionally substituted aryl, substituted biphenylyl and the like, a salt thereof and a pharmaceutical composition comprising the same. The sulfonamide compound is effective for the diseases treatable based on their blood sugar level-depressing activity, cGMP-PDE (especially PDE-V)-inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity, smooth muscle cell suppressing activity, and antiallergic activity.

Abstract: The present invention relates to an agent for prolonging recurrence-free survival time of patients with lung squamous cell carcinoma in the histopathological stage I or an agent for prolonging the survival time or for an agent for prolonging survival time, particularly recurrence-free survival time of patients after surgical resection of lung squamous cell carcinoma in the histopathological stage IB, containing an aminopeptidase inhibitor such as ubenimex as the active ingredient.

Abstract: The present invention relates to a sulfonamide compound of the formula (I): 1